STEERING COMMITTEE
A global Steering Committee is supporting RECARDIO’s strategy and decisions regarding the scientific and clinical development of the pivotal phase 3 study:
ANDREW COATS, PhD, MD (Chairman)
President of the Heart Failure Association, University of Warwick and Monash, United Kingdom/Australia
DEEPAK BHATT, PhD, MD
Executive Director of Interventional Cardiovascular Programs, Professor of Medicine, Harvard Medical School, Boston, USA
TIM FRIEDE, PhD
Department of Medical Statistics, University Medical Center, Göttingen, Germany
CAROLYN LAM, PhD, MD
Director of Women’s Heart Health of the National Heart Centre Singapore Professor of Duke-NUS Cardiovascular Academic Clinical Program, Singapore
DIRK VON LEWINSKI, PhD, MD
Assoc. Prof. in Internal Medicine at the Medical University of Graz, Department of Cardiology; Head of Research unit Myocardial Energetics and Metabolism
RICHARD A. SCHATZ, MD
Interventional Cardiology, Research Director Scripps Clinic, Director of Gene and Stem Cell Research, Professor of Medicine, La Jolla, USA
JOHN TEERLINK, MD
Professor of Medicine, University of California, San Francisco (UCSF)
Director, Heart Failure Program, VA Medical Center, San Francisco, USA
STEPHAN WINDECKER, PhD, MD
Chairman and Professor, Department of Cardiology, Bern University Hospital, Bern, Switzerland
CORPORATE BOARD
DR. ROMAN SCHENK
Dr. Roman Schenk is founder and former CEO of RECARDIO Inc.
He is board member of various health care companies and organizations. Before starting his entrepreneurial career, he held European executive management positions in research, marketing and business development in the pharmaceutical industry.